Vicki(Mughmaw)KeedyMDMSCI

Oncology • Nashville, TN

Sarcoma

Associate Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

Dr. Keedy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Keedy's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-936-2000

Fax+1 615-936-0605

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Vanderbilt University Medical CenterResidency, Internal Medicine, 2002 - 2005
University of Cincinnati College of MedicineClass of 2002

Certifications & Licensure

TN State Medical License 2008 - 2026
AL State Medical License 2020 - 2020
American Board of Internal Medicine Medical Oncology

Clinical Trials

Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer Start of enrollment: 2000 Dec 01
Completed
Not Applicable
Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer Start of enrollment: 2009 May 01
Terminated
Phase 1
Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
Completed
Phase 2
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma Start of enrollment: 2013 Mar 01
Terminated
Not Applicable
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01
Completed
Phase 2
Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Start of enrollment: 2014 Jan 01
Completed
Phase 3
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14
Active, not recruiting
Phase 3
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01
Completed
Phase 1, Phase 2
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) Start of enrollment: 2017 Aug 15
Active, not recruiting
Phase 3
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Start of enrollment: 2019 Aug 13
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

135 citations
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial
Gary K. Schwartz, William D. Tap, Li-Xuan Qin, Michael B. Livingston, Samir D. Undevia
The Lancet. Oncology. 2013-04-01
9 citations
Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma.
Amit Roy, Prashant Gabani, Elizabeth J. Davis, Peter Oppelt, Emily Merfeld
Clinical and Translational Radiation Oncology. 2021-01-28
128 citations
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Margaret von Mehren, John M Kane, Mark Agulnik, Marilyn M Bui, Janai Carr-Ascher
Journal of the National Comprehensive Cancer Network. 2022-07-01

Press Mentions

$Study Finds High-Dose Ifosfamide Superior to Other Standard-of-Care Treatments in Recurrent and Primary Refractory Ewing Sarcomas$
Study Finds High-Dose Ifosfamide Superior to Other Standard-of-Care Treatments in Recurrent and Primary Refractory Ewing SarcomasJune 5th, 2022
An 'Intriguing Failure' in Advanced, Pre-Treated GISTJanuary 26th, 2022
Berlin Assumes New VICC Leadership PostMay 29th, 2018
Join now to see all